These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 14745734)
1. Frequent EpCam protein expression in human carcinomas. Went PT; Lugli A; Meier S; Bundi M; Mirlacher M; Sauter G; Dirnhofer S Hum Pathol; 2004 Jan; 35(1):122-8. PubMed ID: 14745734 [TBL] [Abstract][Full Text] [Related]
2. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Patriarca C; Macchi RM; Marschner AK; Mellstedt H Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002 [TBL] [Abstract][Full Text] [Related]
3. Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity. Imadome K; Iwakawa M; Nakawatari M; Fujita H; Kato S; Ohno T; Nakamura E; Ohkubo Y; Tamaki T; Kiyohara H; Imai T Cancer Biol Ther; 2010 Nov; 10(10):1019-26. PubMed ID: 20855955 [TBL] [Abstract][Full Text] [Related]
4. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Went P; Dirnhofer S; Salvisberg T; Amin MB; Lim SD; Diener PA; Moch H Am J Surg Pathol; 2005 Jan; 29(1):83-8. PubMed ID: 15613858 [TBL] [Abstract][Full Text] [Related]
5. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668 [TBL] [Abstract][Full Text] [Related]
6. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer. Benko G; Spajić B; Krušlin B; Tomas D Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185 [TBL] [Abstract][Full Text] [Related]
7. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. Spizzo G; Fong D; Wurm M; Ensinger C; Obrist P; Hofer C; Mazzoleni G; Gastl G; Went P J Clin Pathol; 2011 May; 64(5):415-20. PubMed ID: 21415054 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays. Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118 [TBL] [Abstract][Full Text] [Related]
9. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877 [TBL] [Abstract][Full Text] [Related]
10. Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma. Eichelberg C; Chun FK; Bedke J; Heuer R; Adam M; Moch H; Terracciano L; Hinrichs K; Dahlem R; Fisch M; Schlomm T; Sauter G; Minner S Int J Cancer; 2013 Jun; 132(12):2948-55. PubMed ID: 23180689 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung. Kim Y; Kim HS; Cui ZY; Lee HS; Ahn JS; Park CK; Park K; Ahn MJ Anticancer Res; 2009 May; 29(5):1817-22. PubMed ID: 19443410 [TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer. Pietzner K; Woopen H; Richter R; Joens T; Braicu EI; Dimitrova D; Mellstedt H; Darb-Esfahani S; Denkert C; Lindhofer H; Fotopoulou C; Sehouli J Int J Gynecol Cancer; 2013 Jun; 23(5):797-802. PubMed ID: 23694980 [TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables. Prince S; Zeidman A; Dekel Y; Ram E; Koren R Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265 [TBL] [Abstract][Full Text] [Related]
15. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors. Heideman DA; Snijders PJ; Craanen ME; Bloemena E; Meijer CJ; Meuwissen SG; van Beusechem VW; Pinedo HM; Curiel DT; Haisma HJ; Gerritsen WR Cancer Gene Ther; 2001 May; 8(5):342-51. PubMed ID: 11477454 [TBL] [Abstract][Full Text] [Related]
16. EpCAM: A new therapeutic target for an old cancer antigen. Armstrong A; Eck SL Cancer Biol Ther; 2003; 2(4):320-6. PubMed ID: 14508099 [TBL] [Abstract][Full Text] [Related]
17. EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features. Laimer K; Fong D; Gastl G; Obrist P; Kloss F; Tuli T; Gassner R; Rasse M; Norer B; Spizzo G Oral Oncol; 2008 Jan; 44(1):72-7. PubMed ID: 17418618 [TBL] [Abstract][Full Text] [Related]
18. Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX. Kim JW; Kim EY; Kim SY; Byun SK; Lee D; Oh KJ; Kim WK; Han BS; Chi SW; Lee SC; Bae KH Mol Cells; 2014 Oct; 37(10):742-6. PubMed ID: 25266702 [TBL] [Abstract][Full Text] [Related]
19. EpCAM expression in the prostate cancer makes the difference in the response to growth factors. Yoshida GJ; Saya H Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103 [TBL] [Abstract][Full Text] [Related]
20. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]